The objective of the program is to understand the relationship and different agreements negotiation processes between biotechnology-based companies and pharmaceutical companies in new compound acquisitions. The main skills and topics are related with international business development, portfolio increase, new valuation compounds, deal terms and conditions, milestones and royalties, and the negotiation process.
Pre-selection process: Open
Inscriptions: from January 2019 to August 2019
The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers.
Credits - 60 / European ECTS credits
Postgraduate Programs – October 2019 to June 2020.
Full Time - Monday to Thursday from 18:00h. to 21:00h.
Language - English